n.a. (MHS)

70.30
NYSE
Prev Close 70.30
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

J&J Taps Bayer Exec For New Post Over 3 Divisions

J&J Taps Bayer Exec For New Post Over 3 Divisions

Johnson & Johnson hiring Bayer exec for new post over consumer health, manufacturing and IT

Link: I'm a Buyer of Bristol Myers in Low $30s

Link: I'm a Buyer of Bristol Myers in Low $30s

Stephanie Link, director of research at TheStreet, says the move in Bristol Myers' stock from the suspension of a Hepatitis C compound has been overdone and sees value in the stock.

Business Highlights

Business Highlights

Business Highlights

Express Scripts and CVS = Real Winners in Walgreen Deal

Express Scripts and CVS = Real Winners in Walgreen Deal

Stephanie Link, director of research at TheStreet, says CVS and Express Scripts are the real winners in Express Scripts' PBM agreement with Walgreen, and is buying CVS on today's pull back.

CVS Has the Right Prescription

CVS Has the Right Prescription

Stephanie Link, director of research at TheStreet, likes CVS for more than the market share they are gaining from Walgreen.

A Quick Review

Let's go over plans for the portfolio in light of today's selling activity.

Redeploying Some Assets

We'll trim a health care position and add to a consumer name and a tech holding.

SXC Health Buys Catalyst for $4.4B as Pill Pushers Consolidate (Update 1)

SXC Health Buys Catalyst for $4.4B as Pill Pushers Consolidate (Update 1)

SXC Health Solutions' acquisition of Catalyst Health Solutions adds to consolidation in the pharmacy benefits space.

5 Most-Popular Stocks for Billionaires

5 Most-Popular Stocks for Billionaires

Before you sacrifice a chunk of your cash to hedge fund managers' fees, try investing in their favorite picks.

US Futures Mixed Before Business Orders Report

US Futures Mixed Before Business Orders Report

US stocks fall after Federal Reserve policy minutes reveal dimmer outlook for jobs, growth

Business Highlights

Business Highlights

Business Highlights

Express Scripts, Medco Deal Gets FTC Approval (Update 1)

Express Scripts, Medco Deal Gets FTC Approval (Update 1)

The FTC has approved a $29 billion acquisition by Express Scripts Deal for Medco Health Solutions.

Tyco, Medco: S&P Gainers

Tyco, Medco: S&P Gainers

These stocks were the best performers in the S&P 500 on Wednesday.

Medco, Toll Brothers, Tyco Hit 52-Week Highs

Medco, Toll Brothers, Tyco Hit 52-Week Highs

These stocks reach 52-week highs on Wednesday.

Medco Health Reaches New 52-Week High (MHS)

Medco Health Reaches New 52-Week High (MHS)

Medco Health Solutions (NYSE:MHS) hit a new 52-week high Wednesday as it is currently trading at $72.29, above its previous 52-week high of $70.97 with 7.8 million shares traded as of 9:35 a.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Finally a Done Deal?

After much scrutiny it looks like a major healthcare merger is clear to close.

'Mad Money Lightning Round: Freeport-McMoRan Will Surprise

'Mad Money Lightning Round: Freeport-McMoRan Will Surprise

Cramer says people will be surprised by the demand for copper.

Medco Health Rises On Unusually High Volume (MHS)

Medco Health Rises On Unusually High Volume (MHS)

Medco Health Solutions (NYSE:MHS) is trading at unusually high volume Tuesday with 13.4 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up $2.13 (+3.1%).

Stocks to Watch: Midas, Urban Outfitters (update 1)

Stocks to Watch: Midas, Urban Outfitters (update 1)

Midas shares are surging in premarket trading Tuesday after TBC said it would buy the company for about $310 million.

5 Things You Need to Know Before the Stock Market Opens

5 Things You Need to Know Before the Stock Market Opens

A policy statement from the Fed and February retail sales are on tap Tuesday.

3 Stocks Reach 52-Week Highs: MAT, CVS, MHS

3 Stocks Reach 52-Week Highs: MAT, CVS, MHS

These stocks hit 52-week highs on Friday.

Medco Health Reaches New 52-Week High (MHS)

Medco Health Reaches New 52-Week High (MHS)

Medco Health Solutions (NYSE:MHS) hit a new 52-week high Friday as it is currently trading at $69.61, above its previous 52-week high of $69.10 with five million shares traded as of 12:50 p.m. ET. Average volume has been 3.3 million shares over the past 30 days.

8 Stocks Billionaire John Paulson Loves

8 Stocks Billionaire John Paulson Loves

Here's a look at eight stocks that Paulson & Co. bought in the fourth quarter.

2 Health Care Stocks Hitting 52-Week Highs: MHS, ISRG

2 Health Care Stocks Hitting 52-Week Highs: MHS, ISRG

These stocks set new 52-week highs on Monday.

Medco Health Reaches New 52-Week High (MHS)

Medco Health Reaches New 52-Week High (MHS)

Medco Health Solutions (NYSE:MHS) hit a new 52-week high Monday as it is currently trading at $67, above its previous 52-week high of $66.38 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Sears, Express Scripts, Medco Are S&P 500 Gainers

Sears, Express Scripts, Medco Are S&P 500 Gainers

These stocks are among the best performers on the S&P 500 midday Thursday.

When Earnings Are Trumped by a Deal

This prescription benefit company had little incentive to blow away numbers as an FTC deal review continues.

Stocks Close Mixed on Greece Bailout Questions

Stocks Close Mixed on Greece Bailout Questions

The Dow fails to hold 13,000 as investors turn cautious on Greece's debt deal.